Drug Shortage Report for LIORESAL INTRATHECAL 2MG/ML

Last updated on 2022-01-17 History
Report ID 148460
Drug Identification Number 02131064
Brand name LIORESAL INTRATHECAL 2MG/ML
Common or Proper name LIORESAL INTRA 10MG/5ML 1 X 5 AMPS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) BACLOFEN
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRATHECAL INTRATHECAL
Packaging size 1X5 AMPS
ATC code M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-11-01
Actual start date
Estimated end date Unknown
Actual end date 2021-11-03
Shortage status Resolved
Updated date 2022-01-17
Company comments Delay in product release.
Health Canada comments
Tier 3 Status No
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-01-17 French Compare
v7 2022-01-17 English Compare
v6 2021-11-02 English Compare
v5 2021-10-28 French Compare
v4 2021-10-28 English Compare
v3 2021-10-28 French Compare
v2 2021-10-28 English Compare
v1 2021-10-28 English Compare

Showing 1 to 8 of 8